Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress

Seres Therapeutics (MCRB) Reports Q2 Loss of $0.69/Share

August 3, 2017 7:21 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($0.69), versus ($0.70) reported last year. Revenue for the quarter came in at $3.01 million, versus $3 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More